Related Experiment Videos
Ha-ras polymorphisms in epithelial ovarian cancer
K O'Briant1, N Chrysson, V Hunter
1Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Gynecologic Oncology
|June 1, 1992
Summary
Researchers investigated unusual restriction fragment length polymorphisms (RFLPs) in the Ha-ras gene for ovarian cancer patients. The study found no significant difference in rare Ha-ras RFLPs between cancer patients and healthy individuals, suggesting they do not distinguish ovarian cancer.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Unusual restriction fragment length polymorphisms (RFLPs) at the Ha-ras locus have been observed in cancer patients' DNA.
- The prevalence of these rare alleles in ovarian cancer requires further investigation.
Purpose of the Study:
- To determine if rare Ha-ras RFLPs are more frequent in patients with ovarian cancer compared to healthy individuals.
- To assess the diagnostic potential of Ha-ras RFLPs in distinguishing ovarian cancer patients.
Main Methods:
- Analysis of Ha-ras RFLPs in DNA from 42 ovarian epithelial tumors and 76 normal peripheral blood leukocyte samples.
- Identification and quantification of common, intermediate, and rare Ha-ras alleles.
Main Results:
- A total of 18 alleles (4 common, 7 intermediate, 7 rare) were detected across all samples.
- Fractions of rare Ha-ras alleles were similar in both ovarian cancer patients and normal individuals.
- The frequency of unusual Ha-ras RFLPs did not differentiate ovarian cancer patients from healthy controls.
Conclusions:
- The frequency of unusual Ha-ras RFLPs does not serve as a distinguishing factor for ovarian cancer.
- Further research may be needed to identify reliable genetic markers for early ovarian cancer detection.